Document is current
Any future updates will be listed below
-
Authors
Murrie, Rhiannon P.
Werdiger, Freda
Donnelley, Martin
Lin, Yu-wei
Carnibella, Richard P.
Samarage, Chaminda R.
Pinar, Isaac
Preissner, Melissa https://orcid.org/0000-0003-2144-9467
Wang, Jiping
Li, Jian
Morgan, Kaye S.
Parsons, David W.
Dubsky, Stephen
Fouras, Andreas
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI132681)
Department of Health | National Health and Medical Research Council (GNT1079712, GNT1055116)
Cystic Fibrosis Foundation (FOURAS1510)
- License Information
-
More Information
Article History
Received: 23 January 2019
Accepted: 15 November 2019
First Online: 16 January 2020
Competing interests
: A.F., C.S., R.C., R.M., S.D. and D.P. have beneficial interests in 4Dx Limited, a company commercialising respiratory diagnostics technology. A.F., S.D. and C.S. are listed on patents filed by Monash University and 4Dx Limited describing the lung imaging technology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.
